RAYMOND JAMES & ASSOCIATES - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$631,714
+55.0%
13,435
+38.3%
0.00%
Q1 2023$407,683
+69.5%
9,716
+54.1%
0.00%
Q4 2022$240,473
-66.9%
6,305
-35.0%
0.00%
-100.0%
Q1 2021$726,000
-34.2%
9,702
-24.0%
0.00%0.0%
Q4 2020$1,104,000
-81.3%
12,760
-86.8%
0.00%
-85.7%
Q3 2020$5,897,000
+418.6%
96,485
+252.9%
0.01%
+250.0%
Q2 2020$1,137,000
+89.2%
27,338
+30.5%
0.00%
+100.0%
Q1 2020$601,000
-3.4%
20,941
+143.2%
0.00%0.0%
Q4 2019$622,000
-87.4%
8,610
-75.6%
0.00%
-85.7%
Q3 2019$4,946,000
-27.8%
35,258
-5.7%
0.01%
-30.0%
Q2 2019$6,846,000
+30.0%
37,391
+12.9%
0.01%
+25.0%
Q1 2019$5,266,000
+144.2%
33,107
+47.1%
0.01%
+100.0%
Q4 2018$2,156,000
-30.2%
22,505
+2.9%
0.00%
-20.0%
Q3 2018$3,090,000
+6.5%
21,874
+18.0%
0.01%0.0%
Q2 2018$2,901,000
+26.6%
18,533
+30.2%
0.01%
+25.0%
Q1 2018$2,292,000
-4.6%
14,229
-2.4%
0.00%0.0%
Q4 2017$2,402,000
+172.0%
14,581
+2.9%
0.00%
+100.0%
Q3 2017$883,000
-51.4%
14,167
-37.9%
0.00%
-50.0%
Q2 2017$1,816,000
+79.4%
22,798
+60.1%
0.00%
+100.0%
Q1 2017$1,012,000
-19.0%
14,237
-41.8%
0.00%
-33.3%
Q4 2016$1,249,000
+266.3%
24,455
+230.3%
0.00%
+200.0%
Q3 2016$341,0007,4040.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders